Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Gilead Sciences Inc (GILD)  
$67.72 0.14 (0.21%) as of 4:30 Fri 5/17


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 1,250,000,000
Market Cap: 84.65(B)
Last Volume: 3,579,101 Avg Vol: 8,731,484
52 Week Range: $64.58 - $87.29
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    S&P COMPOSITE 1500     NASDAQ BIOTECHNOLOGY
    NASDAQ COMPOSITE     NASDAQ-100
    S&P 500     NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  259
Guru Rank Value     : 4.6
Guru Occurances    : 2

 

            6 Months   1 Year   2 Year  
 
Company Profile   Gilead Sciences is a research-based biopharmaceutical company that discovers, develops and commercializes medicines. Co.'s primary areas of focus include viral diseases, inflammatory diseases and oncology. Co.'s products include: Biktarvy® for the treatment of HIV-1 infection in certain patients; Veklury® (remdesivir), for the treatment of Coronavirus Disease 2019 requiring hospitalization; Epclusa® for the treatment of chronic hepatitis C virus infection; Vemlidy® for the treatment of chronic hepatitis B virus infection in adults with compensated liver disease; Yescarta® (axicabtagene ciloleucel) for the treatment of adult patients with relapsed or refractory large B-cell lymphoma.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 12,230 25,472 38,458 80,792
Total Sell Value $890,904 $2,022,270 $3,052,046 $6,445,296
Total People Sold 1 3 3 4
Total Sell Transactions 3 5 9 14
End Date 2024-02-18 2023-11-17 2023-05-19 2022-05-19

   
Records found: 2499
  Page 11 of 100  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Oday Daniel Patrick Chairman & CEO   •       •      –    2021-03-01 4 OE $0.00 $0 D/D 54,286 160,956     -
   Parsey Merdad Chief Medical Officer   •       •      –    2021-02-15 4 A $56.86 $20,696 D/D 364 12,263     -
   Dickinson Andrew D Chief Financial Officer   •       •      –    2021-02-15 4 A $56.86 $20,696 D/D 364 32,907     -
   Pletcher Brett A EVP,Corp Affairs & Gen Counsel   •       •      –    2021-02-15 4 A $56.86 $18,990 D/D 334 29,166     -
   Pletcher Brett A EVP,Corp Affairs & Gen Counsel   •       •      –    2021-02-10 4 AS $67.41 $133,135 D/D (1,975) 28,832 -0%     
   Wilfong Diane E SVP, Controller & CAO   •       •      –    2021-02-10 4 D $67.29 $13,256 D/D (197) 17,409     -
   Wilfong Diane E SVP, Controller & CAO   •       •      –    2021-02-10 4 OE $0.00 $0 D/D 778 17,606     -
   Wilfong Diane E SVP, Controller & CAO   •       •      –    2021-02-06 4 D $68.46 $36,489 D/D (533) 16,828     -
   Wilfong Diane E SVP, Controller & CAO   •       •      –    2021-02-06 4 OE $0.00 $0 D/D 1,866 17,361     -
   Pletcher Brett A EVP,Corp Affairs & Gen Counsel   •       •      –    2021-02-06 4 D $68.46 $51,550 D/D (753) 30,807     -
   Pletcher Brett A EVP,Corp Affairs & Gen Counsel   •       •      –    2021-02-06 4 OE $0.00 $0 D/D 2,728 31,560     -
   Dickinson Andrew D EVP, Chief Financial Officer   •       •      –    2021-02-06 4 D $68.46 $36,831 D/D (538) 32,543     -
   Dickinson Andrew D EVP, Chief Financial Officer   •       •      –    2021-02-06 4 OE $0.00 $0 D/D 1,818 33,081     -
   Pletcher Brett A EVP,Corp Affairs & Gen Counsel   •       •      –    2021-02-01 4 AS $65.97 $640,633 D/D (9,711) 28,832 6%     
   Horning Sandra Director   •       •      –    2021-01-28 4 OE $0.00 $0 D/D 632 632     -
   Mercier Johanna Chief Commercial Officer   •       •      –    2021-01-26 4 A $0.00 $0 D/D 8,068 25,974     -
   Wilfong Diane E SVP, Controller & CAO   •       •      –    2021-01-26 4 A $0.00 $0 D/D 1,294 15,495     -
   Pletcher Brett A EVP,Corp Affairs & Gen Counsel   •       •      –    2021-01-26 4 D $66.70 $249,191 D/D (3,736) 38,543     -
   Pletcher Brett A EVP,Corp Affairs & Gen Counsel   •       •      –    2021-01-26 4 A $0.00 $0 D/D 27,635 42,279     -
   Oday Daniel Patrick Chairman & CEO   •       •      –    2021-01-26 4 A $0.00 $0 D/D 59,100 106,670     -
   Dickinson Andrew D EVP, Chief Financial Officer   •       •      –    2021-01-26 4 D $66.70 $58,563 D/D (878) 31,263     -
   Dickinson Andrew D EVP, Chief Financial Officer   •       •      –    2021-01-26 4 A $0.00 $0 D/D 15,855 32,141     -
   Parsey Merdad Chief Medical Officer   •       •      –    2021-01-26 4 A $0.00 $0 D/D 9,214 11,899     -
   Lofton Kevin E Director   •       •      –    2021-01-22 4 OE $20.65 $418,722 D/D 20,282 74,203     -
   Lofton Kevin E Director   •       •      –    2020-11-23 4 GD $0.00 $0 D/D 21,720 53,921     -
  2499 Records found
  Previous  10  11  12  13  14  15  16  17  18  19  Next   
  Page 11 of 100
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us